Arcus Biosciences
Arcus Biosciences is a United States-based biotechnology company running 4 late-stage cancer trials of Domvanalimab and Quemliclustat in gastric & gastro-oesophageal junction cancer, renal cell carcinoma and pancreatic ductal adenocarcinoma.
Overview
Arcus Biosciences, based in Hayward, the United States, is a biotechnology company. Arcus Biosciences is a clinical-stage biopharmaceutical company that designs small-molecule and antibody combination therapies for cancer. On ClinicalTrials.gov it is the lead sponsor of 4 recruiting or active phase 2 and phase 3 interventional cancer trials (2 in phase 3), testing Domvanalimab and Quemliclustat in gastric & gastro-oesophageal junction cancer, renal cell carcinoma, pancreatic ductal adenocarcinoma and non-small-cell lung cancer. The largest, NCT07011719 (Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma), plans to enrol 720 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.
Scorecard
All companies- phase 3 +6
- modalities +4
Domvanalimab is an experimental monoclonal antibody from Gilead Sciences in phase 3 trials for non-small-cell lung cancer, bladder & urothelial cancer and head and neck squamous cell carcinoma, with its target not yet stated publicly.
Quemliclustat is an experimental investigational agent whose form is not stated in the registry from Arcus Biosciences in phase 3 trials for pancreatic ductal adenocarcinoma and non-small-cell lung cancer, with its target not yet stated publicly.
Similar pages
not linked directly; found by shared links- CompanyCivaTech Oncology
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyOrion, Orion Pharma
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMBrace Therapeutics
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyVyriad
Shares Renal cell carcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyMolecular Partners
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyShenzhen Ionova Life Sciences
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyImmuneering
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.
- CompanyInxMed (Shanghai)
Shares Pancreatic ductal adenocarcinoma, Non-small-cell lung cancer and the tag ctgov-sponsor.